WASHINGTON, D.C. — The U.S. Food and Drug ... removal of oral phenylephrine as an active ingredient in over-the-counter (OTC) monograph drug products intended for nasal decongestion. This ...
WASHINGTON — Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading decongestant ... and Drug Administration formally proposed ...
Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading decongestant found in hundreds of over-the-counter medicines, concluding that ...
After the FDA proposed pulling some over-the ... because it is not effective as a nasal decongestant.” Currently, it is only a proposed administrative order, meaning companies can continue ...
Last month, the U.S. Food and Drug Administration proposed removing phenylephrine ... citing evidence of its ineffectiveness as a nasal decongestant. “Based on our review of available data ...
WASHINGTON (AP) — Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading decongestant found in hundreds of over-the-counter ...